A Leading Pharmaceutical Brand Increased Adherence 29% YoY with Swoop’s Patented Predictive Non-Adherence Audiences
With an increased incidence in substance use disorders (SUDs), a MAT therapy wanted to increase adherence within its patient population to drive positive patient outcomes. Leveraging Swoop’s patented predictive technology, the brand was able to accurately identify patients most likely to become non-adherent and activate them programmatically across premium inventory.
Advertising on CTV Increases HCP Appointments for Mental Health Drug by 20%
A pharmaceutical brand needed to connect with a limited patient population diagnosed with a sensitive conditionand their caregivers. Swoop utilized its privacy-safe real world health data to create a targetable niche segment for activation on CTV platforms.
Help patients start and stay on therapy programs prescribed by their doctors
SwoopRx by Nimble connects prescription fulfillment capabilities with commercial intelligence to turn real-world signals into action, improve medication adherence, and reduce treatment delays.
Swoop’s [ability to] reach our [target] audience as fine tuned as we can in our legal and regulatory environment has been pretty game changing to ensure that we are getting [optimal] audience quality through our campaigns and that we’re ensuring that our dollars are being utilized as efficiently as possible.
Swoop
Improving Patient Outcomes
Swoop improves patient outcomes by connecting the signals that drive earlier diagnosis, better treatment decisions, and sustained adherence.
The integrated, privacy-by-design platform enables life sciences companies to drive measurable patient and commercial outcomes with actionable intelligence — spanning patient and HCP audience targeting, community engagement, AI-powered web solutions, coordinated omnichannel activation, and prescription fulfillment.